HCA's uninsured admissions jump 15% as exchange enrollment plummets 15%

For hospital administrators and clinical leaders, HCA's latest quarterly report is a clear signal: the expiration of premium subsidies is not just a policy abstraction but a real-world driver of patient volume shifts. With uninsured admissions up 15% while exchange admissions fall 15%, emergency departments are facing a surge in uncompensated care, threatening both financial stability and care delivery. The industry must adapt quickly with revenue cycle innovations and patient financial counseling.

HCA Healthcare’s second-quarter 2026 earnings call on July 25 delivered a stark juxtaposition: diluted EPS rose 11% on solid demand, yet a $400 million hit to adjusted EBITDA from an unexpected surge in uninsured patients dominated the conversation and sent a chill through the hospital sector. The trigger is the expiration of enhanced premium tax credits under the Affordable Care Act at the close of 2025, a policy cliff that HCA’s management believed would result in a gradual shift of exchange plan enrollees to other forms of coverage. Instead, CEO Sam Hazen revealed that individuals losing exchange plans migrated “almost one for one” directly into the uninsured pool while continuing to require hospital care, a behavior HCA’s earlier models had not fully captured.

“

Looking ahead, CFO Mike Marks said the company now expects the full‑year EBITDA drag from exchange changes to be between $1 billion and $1.2 billion, a significant revision from earlier expectations.

The financial details are sobering. Same‑facility equivalent admissions from health‑insurance exchanges dropped 15% in the second quarter and on a year‑to‑date basis, while total uninsured equivalent admissions climbed 15%. Meanwhile, admissions among insured patients outside of the exchanges grew 3.2%, demonstrating that underlying demand remains healthy. The payer‑mix deterioration alone created an unfavorable EBITDA impact of approximately $400 million in Q2, a number that included roughly $75 million tied to a higher estimate of the first‑quarter exchange effect. Looking ahead, CFO Mike Marks said the company now expects the full‑year EBITDA drag from exchange changes to be between $1 billion and $1.2 billion, a significant revision from earlier expectations. Underpinning the updated outlook is a new, bleaker assumption: nearly all patients who lose exchange coverage will become uninsured, compared with a prior estimate of 80% to 85%. Equally troubling, the company’s hope that uninsured individuals would consume fewer healthcare services has not materialized.

The implications extend well beyond HCA. The experience is likely a bellwether for the entire hospital industry, where players such as Tenet Healthcare and Community Health Systems face similar exchange exposure. If the pattern holds—formerly subsidized patients flowing into the uninsured column without changing their care‑seeking behavior—margins will compress across the board. For HCA, the $1 billion‑plus headwind represents a material portion of annual EBITDA, pressuring earnings growth and potentially limiting capital for expansions or share buybacks. The stock, which slipped in after‑hours trading following the call, reflects investor unease about a risk that many had viewed as manageable.